Skip to content

An Electrochemical Sensor of Theophylline on a Boron-Doped Diamond Electrode Modified with Nickel Nanoparticles

MetadataDetails
Publication Date2023-10-20
JournalSensors
AuthorsPrastika Krisma Jiwanti, Anis Puspita Sari, Siti Wafiroh, Yeni Wahyuni Hartati, Jarnuzi Gunlazuardi
InstitutionsAirlangga University, Tokyo University of Science
Citations17
AnalysisFull AI Review Included

This study successfully developed a highly precise and selective electrochemical sensor for theophylline by modifying a Boron-Doped Diamond (BDD) electrode with Nickel Nanoparticles (NiNPs) via a simple electrodeposition method.

  • Enhanced Performance: The BDD/NiNP sensor achieved a superior Signal/Background (S/B) ratio of 6.63, significantly higher than the unmodified BDD (1.98), primarily due to a substantial reduction in background current.
  • Low Limit of Detection (LOD): The sensor demonstrated a low LOD of 2.79 ”M, making it suitable for monitoring theophylline within the critical therapeutic range (55 to 110 ”M in plasma).
  • Surface Area Increase: NiNP modification increased the electrochemically active surface area 8-fold, from 0.0011 cm2 (BDD) to 0.0081 cm2 (BDD/NiNP), enhancing electrocatalytic activity.
  • High Accuracy and Precision: Validation in artificial urine samples yielded an excellent recovery of 105.10% and high precision, with a Relative Standard Deviation (%RSD) of 1.65%.
  • Selectivity and Stability: The sensor exhibited strong selectivity against common biological interferents, including D-glucose, urea, and ammonium sulfate.
  • Cost-Effective Modification: The use of non-precious nickel nanoparticles provides a sustainable and low-cost alternative to noble metal modifications for electrochemical sensing.
ParameterValueUnitContext
Active Surface Area (BDD/NiNP)0.0081cm2Calculated via Randles-Sevcik equation
Active Surface Area (BDD)0.0011cm2Unmodified electrode baseline
Limit of Detection (LOD)2.79”MBDD/NiNP sensor performance
Linear Concentration Range30 to 100”MTheophylline sensing range
Signal/Background (S/B) Ratio6.63N/ABDD/NiNP (Optimum pH 3.0)
Sensitivity (BDD/NiNP)0.3002”A/”MCalibration curve slope
Theophylline Oxidation Potential+1.30V (vs Ag/AgCl)Measured via SWV
Optimum pH for Sensing3.0N/A0.1 M Phosphate Buffer Solution (PBS)
Oxidation MechanismIrreversible, diffusion-controlledN/AInvolves 2 protons and 2 electrons
Relative Standard Deviation (%RSD)1.36%Reproducibility (n=8)
Recovery (Artificial Urine)105.10%Real sample analysis
Average Deposited Ni Particle Size82.27nmSEM analysis
NiNP Electrodeposition Potential-1.2VChronoamperometry setting
NiNP Electrodeposition Time250sChronoamperometry setting
  1. BDD Pretreatment: The BDD electrode was cleaned by sonication in 1-propanol and ultrapure water (5 min each). Electrochemical optimization was performed using Cyclic Voltammetry (CV) in 0.1 M H2SO4 (40 scans, 1 V/s scan rate, -2.0 V to +2.0 V range).
  2. NiNP Modification: Nickel Nanoparticles were deposited onto the BDD surface using chronoamperometry.
  3. Deposition Recipe: The precursor solution was 1 mM NiSO4 in 0.1 M acetic buffer (pH 5.5). A constant potential of -1.2 V (vs Ag/AgCl) was applied for 250 s.
  4. Material Characterization: The modified BDD/NiNP electrode was analyzed using Scanning Electron Microscopy (SEM) to confirm homogeneous deposition (average particle size 82.27 nm) and X-ray Photoelectron Spectroscopy (XPS) to verify the presence of metallic Ni (Ni0) and Ni(OH)2 species.
  5. Electrochemical Analysis: Square Wave Voltammetry (SWV) and Cyclic Voltammetry (CV) were used for theophylline detection. The optimal supporting electrolyte was determined to be 0.1 M PBS at pH 3.0.
  6. Performance Validation: The sensor was tested for linearity (30-100 ”M), LOD, selectivity (against urea, D-glucose, ammonium sulfate), and reproducibility (%RSD < 5%).
  7. Real Sample Testing: The standard addition method was applied to artificial urine samples spiked with 60 ”M theophylline to determine accuracy and recovery.
  • Therapeutic Drug Monitoring (TDM): Enables rapid, accurate, and portable monitoring of theophylline levels in patient blood or urine, crucial for managing asthma and chronic pulmonary disorders due to the drug’s narrow therapeutic window.
  • Point-of-Care (POC) Diagnostics: The simplicity and stability of the BDD/NiNP platform are ideal for developing robust, handheld electrochemical sensors for clinical use outside of centralized laboratories.
  • Sustainable Electrocatalysis: Utilizes abundant and low-cost nickel as an effective electrocatalyst, reducing reliance on expensive and scarce noble metals (e.g., Au, Pt) in sensor manufacturing.
  • High-Performance Sensor Platforms: The BDD substrate offers exceptional chemical inertness, low background current, and a wide potential window, making it a preferred material for harsh environment sensing and complex biological matrices.
  • Pharmaceutical Quality Control: Provides a sensitive and precise method for quality assurance testing of drug concentrations in pharmaceutical formulations.
View Original Abstract

Theophylline is a drug with a narrow therapeutic range. Electrochemical sensors are a potentially effective method for detecting theophylline concentration to prevent toxicity. In this work, a simple modification of a boron-doped diamond electrode using nickel nanoparticles was successfully performed for a theophylline electrochemical sensor. The modified electrode was characterized using a scanning electron microscope and X-ray photoelectron spectroscopy. Square wave voltammetry and cyclic voltammetry methods were used to study the electrochemical behavior of theophylline. The modified nickel nanoparticles on the boron-doped diamond electrode exhibited an electrochemically active surface area of 0.0081 cm2, which is larger than the unmodified boron-doped diamond’s area of 0.0011 cm2. This modified electrode demonstrated a low limit of detection of 2.79 ”M within the linear concentration range from 30 to 100 ”M. Moreover, the modified boron-doped diamond electrode also showed selective properties against D-glucose, ammonium sulfate, and urea. In the real sample analysis using artificial urine, the boron-doped diamond electrode with nickel nanoparticle modifications achieved a %recovery of 105.10%, with a good precision of less than 5%. The results of this work indicate that the developed method using nickel nanoparticles on a boron-doped diamond electrode is promising for the determination of theophylline.

  1. 2013 - Theophylline [Crossref]
  2. 2020 - Systemic medications in chronic obstructive pulmonary disease: Use and outcomes [Crossref]
  3. 2016 - Design, synthesis, anticancer, antimicrobial actiities and molecular docking studies of theophylline containing acetylenes and theo-phylline containing 1,2,3-triazoles with variant nucleoside derivatives [Crossref]
  4. 2017 - Pre-diction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants [Crossref]
  5. 2010 - Rapid determination of methylxanthines in real samples by high-performance liquid chromatography using the new FastGradientÂź narrow-bore monolithic column [Crossref]
  6. 2019 - Carbon nanoparticle-protected RNA aptasensor for amplified fluorescent determination of theophylline in serum based on nuclease-aided signal amplification [Crossref]
  7. 2019 - Derivative UV-spectroscopic determination of theophyl-line, salbutamol sulfate and glycerylguaicolate in syrup mixture [Crossref]
  8. 2018 - Highly sensitive gold nanoparticle-based electrochemical aptasensor for the-ophylline detection [Crossref]
  9. 2018 - Highly sensitive determination of the-ophylline based on graphene quantum dots modified electrode [Crossref]